ArticleMedicine2026

Generic versus branded tigecycline for multidrug-resistant gram-negative bacilli and nontuberculous mycobacterial infections: A comparative safety and efficacy analysis.

Rujipas Sirijatuphat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.